Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adverse Event Disclosure Standards Could Be Altered By Supreme Court In Matrixx Case

Executive Summary

Supreme Court justices appeared skeptical of Matrixx Initiatives’ insistence that companies need not tell investors about reports of drug adverse events unless they are statistically significant, suggesting the court may set a different disclosure standard for a securities fraud suit.

You may also be interested in...

Adverse Events Disclosures May Increase After Supreme Court Ruling Against Matrixx, But "Total Mix" Matters

Companies may have to disclose adverse event reports that are not statistically significant, but the court says the amount of disclosure needed can be limited by how much a company tells the market about an issue in general.

Supreme Court To Consider What Adverse Events Pharma Must Report To Avoid Securities Suits

The court will decide whether companies can be sued for failing to disclose adverse event reports that are not statistically significant; the case before the court involves Matrixx's Zicam Cold Remedy products.

Supreme Court Lets Vioxx Securities Suit Against Merck Stand

The top U.S. court clarifies when the statute of limitations for filing suit begins to run and specifies that intent to deceive is crucial in determining if a violation occurred.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts